These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1802594)

  • 1. Relationship between erythropoietin and trace elements.
    Hosokawa S; Oyamaguchi A; Yoshida O
    Contrib Nephrol; 1991; 93():261-3. PubMed ID: 1802594
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of erythropoietin on trace elements in patients with chronic renal failure undergoing hemodialysis.
    Hosokawa S; Yoshida O
    Nephron; 1993; 65(3):414-7. PubMed ID: 8289992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Does aluminum affect the effectiveness of human recombinant erythropoietin in the treatment of anemia in dialyzed patients?].
    Sulková S; Laurincová Z; Kvasnicka J
    Cas Lek Cesk; 1990 Jan; 129(4):113-5. PubMed ID: 2331725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trace elements and complications in patients undergoing chronic hemodialysis.
    Hosokawa S; Oyamaguchi A; Yoshida O
    Nephron; 1990; 55(4):375-9. PubMed ID: 2392189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Erythropoietin treatment in Piedmont and Valle d'Aosta].
    Imarisio P; Biamino E; Bongiorno P; Caligaris F; Demicheli G; Montalcini G; Arnaud A
    Minerva Urol Nefrol; 1991; 43(3):143-5. PubMed ID: 1817336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of erythropoietin in ischemic and arrhythmic cardiopathy of hemodialyzed patients.
    Bellinghieri G; Savica V; De Gregorio C; De Gregorio G
    Contrib Nephrol; 1994; 106():135-7. PubMed ID: 8174359
    [No Abstract]   [Full Text] [Related]  

  • 7. [Factors limiting the correction of anemia with recombinant human erythropoietin].
    Casati S
    Minerva Urol Nefrol; 1991; 43(3):121-3. PubMed ID: 1817332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human erythropoietin reduces free erythrocyte protoporphyrin levels in patients on chronic dialysis.
    Piazza V; Villa G; Galli F; Segagni S; Bovio G; Poggio F; Picardi L; Salvadeo A
    Nephron; 1992; 61(1):54-7. PubMed ID: 1528341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of erythropoietin (rHuEPO) on trace elements and quality of life (Qol) in chronic hemodialysis patients.
    Hosokawa S; Yoshida O
    Int J Clin Pharmacol Ther; 1994 Aug; 32(8):415-21. PubMed ID: 7981926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Erythropoietin, aluminum and renal anemia].
    Schaefer M; Heidland A
    Dtsch Med Wochenschr; 1990 Jun; 115(22):878-9. PubMed ID: 2347300
    [No Abstract]   [Full Text] [Related]  

  • 11. [The effect of extracorporeal hemodialysis on the level of several microelements in the blood of a patient with acute kidney insufficiency].
    Serniak PS; Soroka VR; Semenov GI; Musaelova NI
    Klin Khir (1962); 1967 Jan; 1():6-9. PubMed ID: 5600866
    [No Abstract]   [Full Text] [Related]  

  • 12. Oral zinc supplementation reduces the erythropoietin responsiveness index in patients on hemodialysis.
    Kobayashi H; Abe M; Okada K; Tei R; Maruyama N; Kikuchi F; Higuchi T; Soma M
    Nutrients; 2015 May; 7(5):3783-95. PubMed ID: 25988769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desferrioxamine versus erythropoietin for treatment of dialysis anaemia.
    Padovese P; Gallieni M; Galmozzi C; Brancaccio D
    Lancet; 1990 Jun; 335(8703):1465. PubMed ID: 1972238
    [No Abstract]   [Full Text] [Related]  

  • 14. [Variability of the response to recombinant human erythropoietin in patients undergoing hemodialysis treatment].
    Baroni A; Airoldi G; Agliata S; Fortina F; Ragazzoni E; Cavagnino A; De Nigris A; Cametti G; Ferrero D; Fortina A
    Minerva Urol Nefrol; 1991; 43(3):131-5. PubMed ID: 1817334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reasons for differences in dose requirements of recombinant human erythropoietin in haemodialysis patients.
    Scigalla P; Messinger D; Wieczorek L
    Contrib Nephrol; 1990; 82():55-64. PubMed ID: 2093527
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of aluminum overload on the bone marrow response to recombinant human erythropoietin.
    Grützmacher P; Ehmer B; Messinger D; Kulbe KD; Scigalla P
    Contrib Nephrol; 1989; 76():315-21; discussion 322-3. PubMed ID: 2684530
    [No Abstract]   [Full Text] [Related]  

  • 17. [Utilization of EPO in CAPD].
    Ramello A; Perosa P; Bruno M; Reina E; Rizzuto A; Bertasso L; Roggero A; Malcangi U
    Minerva Urol Nefrol; 1991; 43(3):137-41. PubMed ID: 1817335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased need for blood transfusion during one year after discontinued erythropoietin treatment in haemodialyzed patients.
    Kokot F; Wiecek A; Grzeszczak W
    Nephron; 1991; 58(2):246-7. PubMed ID: 1865988
    [No Abstract]   [Full Text] [Related]  

  • 19. Erythropoietin for anemia of renal failure in sickle cell disease.
    Steinberg MH
    N Engl J Med; 1991 May; 324(19):1369-70. PubMed ID: 1759999
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment with recombinant human erythropoietin in patients with aluminum overload and hyperparathyroidism.
    Grützmacher P; Ehmer B; Limbach J; Messinger D; Kulbe KD; Scigalla P
    Blood Purif; 1990; 8(5):279-84. PubMed ID: 2091687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.